# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001599298-23-000065
Filing Date
2023-06-05
Accepted
2023-06-05 08:43:53
Documents
18
Period of Report
2023-06-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | smmt-20230604.htm iXBRL | 8-K | 38175
2 | EX-99.1 | a2023_prx0604xasco-poste.htm | EX-99.1 | 15332
7 |  | a2023_prx0604xasco-poste001.jpg | GRAPHIC | 229884
8 |  | a2023_prx0604xasco-poste002.jpg | GRAPHIC | 245001
9 |  | a2023_prx0604xasco-poste003.jpg | GRAPHIC | 211379
10 |  | a2023_prx0604xasco-poste004.jpg | GRAPHIC | 223127
| Complete submission text file | 0001599298-23-000065.txt |  | 1483038

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | smmt-20230604.xsd | EX-101.SCH | 2159
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | smmt-20230604_def.xml | EX-101.DEF | 15283
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | smmt-20230604_lab.xml | EX-101.LAB | 29621
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | smmt-20230604_pre.xml | EX-101.PRE | 15940
12 | EXTRACTED XBRL INSTANCE DOCUMENT | smmt-20230604_htm.xml | XML | 11117

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 23991344
SIC: 2834 Pharmaceutical Preparations